The Inflation Reduction Act is keeping drug plan sponsors, pharmacies, Medicare educators and anyone who works with Medicare drug plans very busy.
Many more changes are coming. The biggest one may be the $2,000 cap on Part D drug costs that takes effect in 2025, which has spawned a new program: the Medicare Payment Prescription Plan or MPPP. This may seem simple in concept but it’s really quite complicated. On the website for this new program, the Centers for Medicare and Medicaid Service has nine documents, including fact sheets, cost calculations, timelines, and final guidance, totaling 316 pages.
コメント